Decoy Therapeutics Inc. has announced that a series of antiviral drug candidates previously designed by its Imp3act platform ...

While the rhinovirus is the most common (causing up to 50 percent of all colds), respiratory syncytial virus (RSV), human parainfluenza viruses (HPIVs), and even coronaviruses can also cause colds.

So, all of these respiratory viruses -- influenza, COVID, RSV, human metapneumovirus -- they ... respiratory syncytial virus (RSV) and parainfluenza viruses. The primary mode by which HMPV spreads ...

The new findings may help scientists outsmart these viruses. "Looking at these human cell cultures helps us understand what's going on in people," says Shresta. "Our findings inform how we might ...

Latest data released by the Chinese Center for Disease and Prevention shows a consistent decline in levels of influenza, human parainfluenza virus, rhinovirus and other respiratory pathogens since ...

MEDI-534 is a human–bovine chimeric parainfluenza virus construct expressing the RSV fusion protein. Both candidates show promising safety profiles in Phase I testing and are expected to report ...

Despite important successes, there are no treatments for many common viruses, and antiviral drug resistance is a problem as well. Hospitalized parainfluenza and influenza infections in particular ...

--(BUSINESS WIRE)--Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company developing parainfluenza virus 5 (PIV5 ... which is not known to cause human disease.